Fundraising Fox
/Companies
Sign in

Inventprise

Redmond, US · Founded 2012 · Washington LLC · 91 employees on LinkedIn · 1 known investors

Find your way into Inventprise

Sign up to see every warm intro you have to Inventprise

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Inventprise team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Inventprise is a clinical-stage vaccine developer using its proprietary Hydrazide-PEG-Hydrazide (Hz-PEG-Hz) linker conjugation platform to create conjugate vaccines, including a lead pediatric pneumococcal conjugate vaccine (IVT PCV-25) and candidates for Group B Streptococcus and mRNA-based vaccines. The company also operates automated manufacturing facilities intended to supply global vaccine demand.

BiotechHealthtech

Founders & leadership

Inventprise was founded in 2012 by Subhash Kapre.

SKSubhash Kapre
Subhash KapreFounder · Executive Chairman
PGPradip Ghate
Pradip GhateChief Operating OfficerPradip Ghate brings nearly four decades of experience in vaccine and injectable manufacturing, with expertise spanning development, production, operations, and executive leadership across pharmaceutical and biological products. He has a track record of securing multimillion-dollar grants and proposals for vaccine and biotech initiatives.
DG
David GoeslingChief Financial Officer
YLYves Leurquin
Yves LeurquinChief Executive OfficerHe brings more than 30 years of experience in general management, marketing, go-to-market strategy, sales, and government affairs across vaccine development and launch, with engagement across Europe, Latin America, the Middle East, Africa, and Asia.

Investors · 1

Reported raises · per SEC filings

Form D private placements

$3.5M disclosed across 1 round · 2021

▶$3.5MraisedNov 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Pradip GhateExecutive Officer
  • David GoeslingExecutive Officer
  • Subhash KapreExecutive Officer, Director
  • Yves LeurquinExecutive Officer
Offering amount
$95M
Amount sold
$3.5M
First sale
Nov 2021
Incorporated
Limited Liability Company, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Inventprise went on to found or lead other companies.

Emily Egerton-WarburtonVaccine R&D InternFounded Ligo BiosciencesAndrew FarnumMember Board of DirectorsFounded Variant Bio

Related companies · 2

IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
VaxcyteVaxcyte is a clinical-stage biotechnology company developing vaccines to prevent or treat bacterial infectious diseases, including pneumococcal conjugate vaccine candidates. Founded in 2013, it uses a cell-free protein synthesis platform to engineer vaccines for children and adults.

Companies working in the same space as Inventprise.

In the news

Inventprise Receives $30M, Appoints New CEO and Expands Corporate Board - Inventpriseinventprise.com · Apr 2022Inventprise Announces Investment of up to $90 Million to Advance its 25 Valent Pneumococcal Conjugate Vaccine Candidate into Proof-of-Concept Clinical Trials - Inventpriseinventprise.com · Nov 2021Seattle-area startup Inventprise gets backing from Gates Foundation for pneumonia shot – GeekWiregeekwire.com · Nov 2021

Frequently asked questions

What does Inventprise do?
Inventprise is a clinical-stage vaccine developer using its proprietary Hydrazide-PEG-Hydrazide (Hz-PEG-Hz) linker conjugation platform to create conjugate vaccines, including a lead pediatric pneumococcal conjugate vaccine (IVT PCV-25) and candidates for Group B Streptococcus and mRNA-based vaccines. The company also operates automated manufacturing facilities intended to supply global vaccine demand.
Who founded Inventprise?
Inventprise was founded by Subhash Kapre in 2012.
Who are Inventprise's investors?
Inventprise's investors include Bill & Melinda Gates Foundation.
How much funding has Inventprise raised?
Inventprise has disclosed $3.5M raised across 1 round.
Where is Inventprise headquartered?
Inventprise is headquartered in Redmond, US.